Two Sigma Investments LP Sells 27,972 Shares of Ardent Health Partners, LLC (NYSE:ARDT)

Two Sigma Investments LP lessened its position in shares of Ardent Health Partners, LLC (NYSE:ARDT) by 53.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 24,841 shares of the company’s stock after selling 27,972 shares during the period. Two Sigma Investments LP’s holdings in Ardent Health Partners were worth $424,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Point72 Asia Singapore Pte. Ltd. acquired a new position in Ardent Health Partners during the fourth quarter valued at approximately $27,000. US Bancorp DE bought a new stake in Ardent Health Partners during the fourth quarter valued at $31,000. New York State Common Retirement Fund bought a new stake in Ardent Health Partners during the fourth quarter valued at $48,000. Deutsche Bank AG boosted its position in shares of Ardent Health Partners by 1,251.9% during the 4th quarter. Deutsche Bank AG now owns 2,866 shares of the company’s stock worth $49,000 after purchasing an additional 2,654 shares in the last quarter. Finally, Wells Fargo & Company MN boosted its position in shares of Ardent Health Partners by 52.6% during the 4th quarter. Wells Fargo & Company MN now owns 8,704 shares of the company’s stock worth $149,000 after purchasing an additional 3,002 shares in the last quarter.

Ardent Health Partners Trading Down 8.3%

Shares of ARDT stock opened at $13.63 on Tuesday. The company has a 50-day moving average of $13.51 and a two-hundred day moving average of $14.56. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. Ardent Health Partners, LLC has a 1-year low of $11.31 and a 1-year high of $20.72. The firm has a market cap of $1.95 billion and a PE ratio of 8.36.

Ardent Health Partners (NYSE:ARDT) last released its quarterly earnings data on Tuesday, May 6th. The company reported $0.29 earnings per share for the quarter, topping analysts’ consensus estimates of $0.21 by $0.08. The company had revenue of $1.50 billion for the quarter, compared to analyst estimates of $1.50 billion. On average, analysts predict that Ardent Health Partners, LLC will post 1.23 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on ARDT shares. Stephens reiterated an “overweight” rating and issued a $21.00 price objective on shares of Ardent Health Partners in a research note on Tuesday, May 20th. Mizuho reduced their price objective on shares of Ardent Health Partners from $19.00 to $18.00 and set an “outperform” rating for the company in a research note on Wednesday, April 9th. Guggenheim lifted their price objective on shares of Ardent Health Partners from $16.00 to $18.00 and gave the stock a “buy” rating in a report on Friday, May 9th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $21.00 price objective on shares of Ardent Health Partners in a report on Thursday, May 15th. Two analysts have rated the stock with a hold rating, nine have assigned a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Ardent Health Partners currently has an average rating of “Buy” and a consensus target price of $20.67.

Ardent Health Partners Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.